Oxygen therapy for cancer in Japan
The Japanese cure for cancer and treatment of cancer in Japan is very advanced. However, the inventor of “Eating Oxygen” is confident that his invention is very useful for alternative cancer treatment in Japan or in any country of the world. Below are the comments from world renown Professors & Doctors with similar concept. Supply of enough Oxygen in effected cells is Japanese natural cancer treatment.
Otto Heinrich Warburg, a German medical doctor, physiologist and scientist, received a Nobel Prize in 1931 for the revolutionary breakthrough. He was the one to discover that an unhealthy diet and lake of Oxygen creates an acidic environment within the body, which allows for the development of cancer. Oxygen is removed from cells within an acidic environment, cancer cells thrive in this environment. In order for cancer cells to grow and spread, they require glucose and anaerobic conditions. Tumor tissues are acidic while healthy tissues are alkaline. If 35% of a healthy cell’s oxygen is removed, the cell will turn into a cancer cell within two days, according to Warburg.
Prof. Keith Scott-Mumbg (MD, MB ChB, PhD) a well-known cancer specialist said, Cancer cells have a non-oxygen metabolism. Sugar is their preferred choice of fuel, while Oxygen therapy is a safe and effective method to kill cancer cells without ravaging the patient’s immune system in the process.
Role of oxygen in cancer by: Lopez-Lazaro
Although cancer is considered to be a disease caused by DNA alterations, the high genetic variability of tumor cells makes it difficult to exploit these alterations for the treatment of cancer. The influence of non-genetic factors on cancer is increasingly being acknowledged and a growing line of research suggests that hypoxia (a decrease in normal oxygen levels) may play a fundamental role in the development of this disease. This line of research is supported by the fact that tumors often have hypoxic areas, that hypoxia activates the hypoxia-inducible factor 1 (HIF-1) and that HIF-1 activation plays a key role in cancer development. Evidence suggests, however, that the idea of hypoxia playing a central role in cancer development has some drawbacks. For instance, hypoxia has not been found in many tumors, HIF-1 activation has been observed in non-hypoxic tumor areas, and hypoxic tumor cells commonly have a reduced nutrient supply that restricts cell proliferation and tumor growth. This article reviews the literature that does not support the idea of hypoxia playing a central role in cancer development and discusses a broader view in which the role of oxygen in cancer is not limited to a reduction in its normal levels, a deviation of the oxygen metabolism from the pathway that generates energy to the pathway that produces reactive oxygen species is crucial for cancer development. Interestingly, this switch in oxygen metabolism occurs under both hypoxic and normoxic conditions and may be exploited therapeutically.